$CTIC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CTI BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CTI BIOPHARMA CORP. Get notifications about new insider transactions in CTI BIOPHARMA CORP for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 13 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.95 | 400 | 780 | 686,340 | 686.7 K to 686.3 K (-0.06 %) |
Jul 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.95 | 1,200 | 2,334 | 686,740 | 687.9 K to 686.7 K (-0.17 %) |
Jul 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.93 | 1,700 | 3,281 | 687,940 | 689.6 K to 687.9 K (-0.25 %) |
Jul 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.93 | 100 | 193 | 689,640 | 689.7 K to 689.6 K (-0.01 %) |
Jul 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.93 | 700 | 1,348 | 689,740 | 690.4 K to 689.7 K (-0.10 %) |
Jul 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.92 | 1,300 | 2,496 | 690,440 | 691.7 K to 690.4 K (-0.19 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 2.11 | 700 | 1,477 | 1,290,919 | 1.3 M to 1.3 M (-0.05 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 2.11 | 200 | 421 | 1,291,619 | 1.3 M to 1.3 M (-0.02 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 2.10 | 1,200 | 2,520 | 1,291,819 | 1.3 M to 1.3 M (-0.09 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 2.09 | 100 | 209 | 1,293,019 | 1.3 M to 1.3 M (-0.01 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 2.08 | 200 | 416 | 1,293,119 | 1.3 M to 1.3 M (-0.02 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 2.08 | 500 | 1,038 | 1,293,319 | 1.3 M to 1.3 M (-0.04 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 2.07 | 2,200 | 4,554 | 1,293,819 | 1.3 M to 1.3 M (-0.17 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 2.07 | 4,300 | 8,880 | 1,296,019 | 1.3 M to 1.3 M (-0.33 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 2.06 | 3,500 | 7,210 | 1,300,319 | 1.3 M to 1.3 M (-0.27 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 2.06 | 100 | 206 | 1,303,819 | 1.3 M to 1.3 M (-0.01 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 2.05 | 1,200 | 2,460 | 1,303,919 | 1.3 M to 1.3 M (-0.09 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 2.05 | 400 | 818 | 1,305,119 | 1.3 M to 1.3 M (-0.03 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 2.04 | 400 | 816 | 1,305,519 | 1.3 M to 1.3 M (-0.03 %) |
Jun 26 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.18 | 10,000 | 21,800 | 925,416 | 935.4 K to 925.4 K (-1.07 %) |
Jun 05 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.08 | 100 | 208 | 691,740 | 691.8 K to 691.7 K (-0.01 %) |
Jun 05 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.08 | 200 | 415 | 691,840 | 692 K to 691.8 K (-0.03 %) |
Jun 05 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.07 | 3,700 | 7,659 | 692,040 | 695.7 K to 692 K (-0.53 %) |
Jun 05 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.07 | 100 | 207 | 695,740 | 695.8 K to 695.7 K (-0.01 %) |
Jun 05 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.06 | 2,400 | 4,944 | 695,840 | 698.2 K to 695.8 K (-0.34 %) |
Jun 05 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.06 | 1,000 | 2,055 | 698,240 | 699.2 K to 698.2 K (-0.14 %) |
Jun 05 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.05 | 2,500 | 5,125 | 699,240 | 701.7 K to 699.2 K (-0.36 %) |
May 22 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 1.80 | 10,000 | 18,000 | 935,416 | 945.4 K to 935.4 K (-1.06 %) |
May 22 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.76 | 100 | 176 | 1,305,919 | 1.3 M to 1.3 M (-0.01 %) |
May 22 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.75 | 4,400 | 7,700 | 1,306,019 | 1.3 M to 1.3 M (-0.34 %) |
May 22 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.74 | 400 | 696 | 1,310,419 | 1.3 M to 1.3 M (-0.03 %) |
May 22 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.73 | 10,100 | 17,473 | 1,310,819 | 1.3 M to 1.3 M (-0.76 %) |
May 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.87 | 600 | 1,119 | 701,740 | 702.3 K to 701.7 K (-0.09 %) |
May 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.86 | 3,000 | 5,580 | 702,340 | 705.3 K to 702.3 K (-0.43 %) |
May 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.86 | 2,700 | 5,009 | 705,340 | 708 K to 705.3 K (-0.38 %) |
May 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.85 | 3,700 | 6,845 | 708,040 | 711.7 K to 708 K (-0.52 %) |
May 01 2015 | CTIC | CTI BIOPHARMA CORP | Baxter Healthcare SA | 10% Owner | Sell | J | 0.00 | 15,673,981 | 0 | 0 | 15.7 M to 0 (-100.00 %) |
Apr 27 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.98 | 3,200 | 6,336 | 1,320,919 | 1.3 M to 1.3 M (-0.24 %) |
Apr 27 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.97 | 3,200 | 6,304 | 1,324,119 | 1.3 M to 1.3 M (-0.24 %) |
Apr 27 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.97 | 60 | 118 | 1,327,319 | 1.3 M to 1.3 M (0.00 %) |
Apr 27 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.96 | 300 | 589 | 1,327,379 | 1.3 M to 1.3 M (-0.02 %) |
Apr 27 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.96 | 3,440 | 6,742 | 1,327,679 | 1.3 M to 1.3 M (-0.26 %) |
Apr 27 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.96 | 1,200 | 2,346 | 1,331,119 | 1.3 M to 1.3 M (-0.09 %) |
Apr 27 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.95 | 1,900 | 3,705 | 1,332,319 | 1.3 M to 1.3 M (-0.14 %) |
Apr 27 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.95 | 1,100 | 2,140 | 1,334,219 | 1.3 M to 1.3 M (-0.08 %) |
Apr 27 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.94 | 600 | 1,164 | 1,335,319 | 1.3 M to 1.3 M (-0.04 %) |
Apr 24 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP,Finance and Adm ... | Sell | S | 1.93 | 10,000 | 19,300 | 945,416 | 955.4 K to 945.4 K (-1.05 %) |
Apr 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.92 | 300 | 576 | 711,740 | 712 K to 711.7 K (-0.04 %) |
Apr 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.92 | 100 | 192 | 712,040 | 712.1 K to 712 K (-0.01 %) |
Apr 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.91 | 1,400 | 2,674 | 712,140 | 713.5 K to 712.1 K (-0.20 %) |
Apr 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.91 | 100 | 191 | 713,540 | 713.6 K to 713.5 K (-0.01 %) |
Apr 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.90 | 1,600 | 3,040 | 713,640 | 715.2 K to 713.6 K (-0.22 %) |
Apr 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.90 | 100 | 190 | 715,240 | 715.3 K to 715.2 K (-0.01 %) |
Apr 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.89 | 1,400 | 2,646 | 715,340 | 716.7 K to 715.3 K (-0.20 %) |
Apr 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.89 | 2,000 | 3,770 | 716,740 | 718.7 K to 716.7 K (-0.28 %) |
Apr 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.88 | 1,900 | 3,572 | 718,740 | 720.6 K to 718.7 K (-0.26 %) |
Apr 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.88 | 769 | 1,442 | 720,640 | 721.4 K to 720.6 K (-0.11 %) |
Apr 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.87 | 5,300 | 9,911 | 721,409 | 726.7 K to 721.4 K (-0.73 %) |
Apr 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.87 | 800 | 1,492 | 726,709 | 727.5 K to 726.7 K (-0.11 %) |
Apr 08 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.86 | 800 | 1,488 | 727,509 | 728.3 K to 727.5 K (-0.11 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.98 | 2,330 | 4,613 | 728,309 | 730.6 K to 728.3 K (-0.32 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.98 | 2,216 | 4,377 | 730,639 | 732.9 K to 730.6 K (-0.30 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.97 | 5,184 | 10,212 | 732,855 | 738 K to 732.9 K (-0.70 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.97 | 11,700 | 22,991 | 738,039 | 749.7 K to 738 K (-1.56 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.96 | 28,197 | 55,266 | 749,739 | 777.9 K to 749.7 K (-3.62 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.96 | 7,903 | 15,450 | 777,936 | 785.8 K to 777.9 K (-1.01 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.95 | 1,600 | 3,120 | 785,839 | 787.4 K to 785.8 K (-0.20 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Payment of Exercise | F | 1.94 | 59,784 | 115,682 | 787,439 | 847.2 K to 787.4 K (-7.06 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Payment of Exercise | F | 1.94 | 66,736 | 129,134 | 955,416 | 1 M to 955.4 K (-6.53 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 1.95 | 175,199 | 341,112 | 3,313,916 | 3.5 M to 3.3 M (-5.02 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Payment of Exercise | F | 1.94 | 12,461 | 24,112 | 3,489,115 | 3.5 M to 3.5 M (-0.36 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Payment of Exercise | F | 1.94 | 93,970 | 181,832 | 1,335,919 | 1.4 M to 1.3 M (-6.57 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.96 | 3,600 | 7,056 | 1,429,889 | 1.4 M to 1.4 M (-0.25 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.95 | 19,600 | 38,220 | 1,433,489 | 1.5 M to 1.4 M (-1.35 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.94 | 2,900 | 5,635 | 1,453,089 | 1.5 M to 1.5 M (-0.20 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.94 | 18,600 | 36,084 | 1,455,989 | 1.5 M to 1.5 M (-1.26 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.93 | 16,200 | 31,266 | 1,474,589 | 1.5 M to 1.5 M (-1.09 %) |
Mar 24 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.92 | 6,700 | 12,864 | 1,490,789 | 1.5 M to 1.5 M (-0.45 %) |
Mar 20 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 1.96 | 2,100 | 4,116 | 1,022,152 | 1 M to 1 M (-0.21 %) |
Mar 20 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 1.95 | 11,500 | 22,425 | 1,024,252 | 1 M to 1 M (-1.11 %) |
Mar 20 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 1.94 | 5,100 | 9,909 | 1,035,752 | 1 M to 1 M (-0.49 %) |
Mar 20 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 1.94 | 17,100 | 33,174 | 1,040,852 | 1.1 M to 1 M (-1.62 %) |
Mar 20 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 1.93 | 15,900 | 30,687 | 1,057,952 | 1.1 M to 1.1 M (-1.48 %) |
Mar 20 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 1.92 | 1,300 | 2,500 | 1,073,852 | 1.1 M to 1.1 M (-0.12 %) |
Mar 20 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 1.92 | 10,000 | 19,200 | 1,075,152 | 1.1 M to 1.1 M (-0.92 %) |
Mar 11 2015 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Gift | G | 0.00 | 46,535 | 0 | 354,644 | 401.2 K to 354.6 K (-11.60 %) |
Mar 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.44 | 1,100 | 2,684 | 847,223 | 848.3 K to 847.2 K (-0.13 %) |
Mar 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.44 | 200 | 487 | 848,323 | 848.5 K to 848.3 K (-0.02 %) |
Mar 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.43 | 600 | 1,458 | 848,523 | 849.1 K to 848.5 K (-0.07 %) |
Mar 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.43 | 200 | 485 | 849,123 | 849.3 K to 849.1 K (-0.02 %) |
Mar 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.42 | 2,800 | 6,776 | 849,323 | 852.1 K to 849.3 K (-0.33 %) |
Mar 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.42 | 300 | 725 | 852,123 | 852.4 K to 852.1 K (-0.04 %) |
Mar 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.41 | 1,700 | 4,097 | 852,423 | 854.1 K to 852.4 K (-0.20 %) |
Mar 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.41 | 1,000 | 2,405 | 854,123 | 855.1 K to 854.1 K (-0.12 %) |
Mar 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.40 | 1,800 | 4,320 | 855,123 | 856.9 K to 855.1 K (-0.21 %) |
Mar 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.40 | 1,100 | 2,635 | 856,923 | 858 K to 856.9 K (-0.13 %) |
Mar 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.39 | 1,200 | 2,868 | 858,023 | 859.2 K to 858 K (-0.14 %) |
Feb 27 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP Global Medical ... | Sell | S | 2.36 | 200 | 471 | 1,497,489 | 1.5 M to 1.5 M (-0.01 %) |
Feb 27 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP Global Medical ... | Sell | S | 2.35 | 14,800 | 34,780 | 1,497,689 | 1.5 M to 1.5 M (-0.98 %) |
Feb 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.26 | 200 | 452 | 859,223 | 859.4 K to 859.2 K (-0.02 %) |
Feb 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.25 | 600 | 1,350 | 859,423 | 860 K to 859.4 K (-0.07 %) |
Feb 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.24 | 500 | 1,120 | 860,023 | 860.5 K to 860 K (-0.06 %) |
Feb 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.24 | 300 | 671 | 860,523 | 860.8 K to 860.5 K (-0.03 %) |
Feb 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.23 | 1,600 | 3,568 | 860,823 | 862.4 K to 860.8 K (-0.19 %) |
Feb 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.23 | 800 | 1,780 | 862,423 | 863.2 K to 862.4 K (-0.09 %) |
Feb 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.22 | 3,700 | 8,214 | 863,223 | 866.9 K to 863.2 K (-0.43 %) |
Feb 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.22 | 1,100 | 2,437 | 866,923 | 868 K to 866.9 K (-0.13 %) |
Feb 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.21 | 1,900 | 4,199 | 868,023 | 869.9 K to 868 K (-0.22 %) |
Feb 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.21 | 200 | 441 | 869,923 | 870.1 K to 869.9 K (-0.02 %) |
Feb 06 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.20 | 1,100 | 2,420 | 870,123 | 871.2 K to 870.1 K (-0.13 %) |
Feb 06 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.23 | 100 | 223 | 1,085,152 | 1.1 M to 1.1 M (-0.01 %) |
Feb 06 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.22 | 9,900 | 21,978 | 1,085,252 | 1.1 M to 1.1 M (-0.90 %) |
Jan 09 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Grant | A | 0.00 | 477,255 | 0 | 871,223 | 394 K to 871.2 K (+121.14 %) |
Jan 09 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Grant | A | 0.00 | 477,255 | 0 | 1,095,152 | 617.9 K to 1.1 M (+77.24 %) |
Jan 09 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.33 | 900 | 2,093 | 617,897 | 618.8 K to 617.9 K (-0.15 %) |
Jan 09 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.32 | 400 | 929 | 618,797 | 619.2 K to 618.8 K (-0.06 %) |
Jan 09 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.32 | 8,700 | 20,184 | 619,197 | 627.9 K to 619.2 K (-1.39 %) |
Jan 09 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Grant | A | 0.00 | 477,255 | 0 | 1,512,489 | 1 M to 1.5 M (+46.10 %) |
Jan 09 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Grant | A | 0.00 | 1,590,850 | 0 | 3,501,576 | 1.9 M to 3.5 M (+83.26 %) |
Jan 07 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.38 | 1,000 | 2,375 | 393,968 | 395 K to 394 K (-0.25 %) |
Jan 07 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.37 | 5,700 | 13,509 | 394,968 | 400.7 K to 395 K (-1.42 %) |
Jan 07 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.37 | 600 | 1,419 | 400,668 | 401.3 K to 400.7 K (-0.15 %) |
Jan 07 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.36 | 2,300 | 5,428 | 401,268 | 403.6 K to 401.3 K (-0.57 %) |
Jan 07 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.36 | 1,000 | 2,355 | 403,568 | 404.6 K to 403.6 K (-0.25 %) |
Jan 07 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.35 | 100 | 235 | 404,568 | 404.7 K to 404.6 K (-0.02 %) |
Jan 07 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.35 | 300 | 704 | 404,668 | 405 K to 404.7 K (-0.07 %) |
Jan 07 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.34 | 1,000 | 2,340 | 404,968 | 406 K to 405 K (-0.25 %) |
Dec 19 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 2.50 | 5,000 | 12,500 | 1,910,726 | 1.9 M to 1.9 M (-0.26 %) |
Dec 19 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 2.48 | 1,588 | 3,930 | 1,915,726 | 1.9 M to 1.9 M (-0.08 %) |
Dec 19 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 2.47 | 8,412 | 20,778 | 1,917,314 | 1.9 M to 1.9 M (-0.44 %) |
Dec 19 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 2.46 | 3,800 | 9,348 | 1,925,726 | 1.9 M to 1.9 M (-0.20 %) |
Dec 19 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 2.45 | 1,200 | 2,940 | 1,929,526 | 1.9 M to 1.9 M (-0.06 %) |
Dec 19 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 2.42 | 400 | 966 | 1,930,726 | 1.9 M to 1.9 M (-0.02 %) |
Dec 19 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 2.41 | 9,600 | 23,136 | 1,931,126 | 1.9 M to 1.9 M (-0.49 %) |
Dec 19 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 2.41 | 400 | 962 | 1,940,726 | 1.9 M to 1.9 M (-0.02 %) |
Dec 19 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 2.40 | 4,600 | 11,040 | 1,941,126 | 1.9 M to 1.9 M (-0.24 %) |
Dec 19 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 2.40 | 100 | 240 | 1,945,726 | 1.9 M to 1.9 M (-0.01 %) |
Dec 19 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 2.39 | 4,900 | 11,711 | 1,945,826 | 2 M to 1.9 M (-0.25 %) |
Dec 05 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.26 | 5,900 | 13,305 | 627,897 | 633.8 K to 627.9 K (-0.93 %) |
Dec 05 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.25 | 4,100 | 9,225 | 633,797 | 637.9 K to 633.8 K (-0.64 %) |
Dec 05 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.25 | 1,200 | 2,700 | 405,968 | 407.2 K to 406 K (-0.29 %) |
Dec 05 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.25 | 400 | 898 | 407,168 | 407.6 K to 407.2 K (-0.10 %) |
Dec 05 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.24 | 300 | 672 | 407,568 | 407.9 K to 407.6 K (-0.07 %) |
Dec 05 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.24 | 3,900 | 8,717 | 407,868 | 411.8 K to 407.9 K (-0.95 %) |
Dec 05 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.23 | 5,400 | 12,042 | 411,768 | 417.2 K to 411.8 K (-1.29 %) |
Dec 05 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.23 | 600 | 1,335 | 417,168 | 417.8 K to 417.2 K (-0.14 %) |
Dec 05 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.22 | 200 | 444 | 417,768 | 418 K to 417.8 K (-0.05 %) |
Nov 07 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.37 | 100 | 237 | 637,897 | 638 K to 637.9 K (-0.02 %) |
Nov 07 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 2.37 | 9,900 | 23,463 | 637,997 | 647.9 K to 638 K (-1.53 %) |
Nov 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.41 | 1,700 | 4,089 | 417,968 | 419.7 K to 418 K (-0.41 %) |